Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
63.06
-0.69 (-1.08%)
May 29, 2026, 4:00 PM EDT - Market closed
Merit Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,542 | 1,516 | 1,357 | 1,257 | 1,151 | 1,075 | |
Revenue Growth (YoY) | 11.10% | 11.75% | 7.89% | 9.24% | 7.09% | 11.50% |
Cost of Revenue | 791.39 | 777.64 | 713.18 | 673.49 | 631.88 | 589.42 |
Gross Profit | 751.05 | 738.27 | 643.33 | 583.87 | 519.1 | 485.33 |
Selling, General & Admin | 465.94 | 455.21 | 399.73 | 373.68 | 342.53 | 335.69 |
Research & Development | 97.48 | 97.35 | 87.47 | 82.73 | 75.51 | 71.25 |
Other Operating Expenses | -0.22 | 0.98 | 0.44 | 3.52 | 13.5 | 17.48 |
Total Operating Expenses | 563.2 | 553.55 | 487.64 | 459.93 | 431.54 | 424.42 |
Operating Income | 187.84 | 184.72 | 155.69 | 123.94 | 87.56 | 60.92 |
Interest Income | 15.18 | 15.07 | 26.23 | 2.46 | 0.44 | 0.77 |
Interest Expense | -26.42 | -26.46 | -31.22 | -15.51 | -6.34 | -5.26 |
Other Non-Operating Income (Expense) | 9.92 | -2.39 | -0.71 | 1.2 | 0.97 | -2.51 |
Total Non-Operating Income (Expense) | -1.32 | -13.78 | -5.7 | -11.86 | -4.93 | -7 |
Pretax Income | 186.53 | 170.94 | 149.99 | 112.09 | 82.63 | 53.92 |
Provision for Income Taxes | 47.19 | 42.45 | 29.64 | 17.68 | 8.11 | 5.46 |
Net Income | 139.34 | 128.49 | 120.36 | 94.41 | 74.52 | 48.45 |
Net Income to Common | 139.34 | 128.49 | 120.36 | 94.41 | 74.52 | 48.45 |
Net Income Growth | 13.96% | 6.76% | 27.48% | 26.70% | 53.79% | - |
Shares Outstanding (Basic) | 59 | 59 | 58 | 58 | 57 | 56 |
Shares Outstanding (Diluted) | 60 | 60 | 59 | 58 | 58 | 57 |
Shares Change (YoY) | 0.17% | 1.85% | 1.73% | 1.19% | 0.54% | 3.47% |
EPS (Basic) | 2.35 | 2.17 | 2.07 | 1.64 | 1.31 | 0.86 |
EPS (Diluted) | 2.31 | 2.13 | 2.03 | 1.62 | 1.29 | 0.84 |
EPS Growth | 13.23% | 4.93% | 25.31% | 25.58% | 53.57% | - |
Shares Outstanding | 59.66 | 59.42 | 58.74 | 57.86 | 57.31 | 56.57 |
Free Cash Flow | 220.82 | 215.66 | 185.66 | 110.86 | 69.26 | 119.29 |
Free Cash Flow Growth | 2.39% | 16.16% | 67.47% | 60.06% | -41.94% | 0.01% |
Free Cash Flow Per Share | 3.67 | 3.57 | 3.13 | 1.90 | 1.20 | 2.08 |
Gross Margin | 48.69% | 48.70% | 47.43% | 46.44% | 45.10% | 45.16% |
Operating Margin | 12.18% | 12.19% | 11.48% | 9.86% | 7.61% | 5.67% |
Profit Margin | 9.03% | 8.48% | 8.87% | 7.51% | 6.47% | 4.51% |
FCF Margin | 14.32% | 14.23% | 13.69% | 8.82% | 6.02% | 11.10% |
EBITDA | 312.22 | 307.89 | 258.4 | 213.93 | 169.37 | 144.98 |
EBITDA Margin | 20.24% | 20.31% | 19.05% | 17.01% | 14.71% | 13.49% |
EBIT | 187.84 | 184.72 | 155.69 | 123.94 | 87.56 | 60.92 |
EBIT Margin | 12.18% | 12.19% | 11.48% | 9.86% | 7.61% | 5.67% |
Effective Tax Rate | 25.30% | 24.83% | 19.76% | 15.77% | 9.82% | 10.13% |